Celia Quevedo

Ph.D. in Biology at Universidad Complutense of Madrid (Spain) and postdoctoral at Cancer Research Program at the Hospital for Sick Children (HSC, Toronto, Canada) for 4 years as well as 2 years at the Cancer Research Center of Salamanca (Spain). She started working in Biobide in 2008 to develop transgenic and mutant zebrafish models and she specialized in developing and directing toxicity assays such as acute toxicity, developmental toxicity or otic toxicity.